Literature DB >> 26228897

Pathogen Stimulation History Impacts Donor-Specific CD8(+) T Cell Susceptibility to Costimulation/Integrin Blockade-Based Therapy.

I R Badell1, W H Kitchens1, M E Wagener1, A E Lukacher2, C P Larsen1, M L Ford1.   

Abstract

Recent studies have shown that the quantity of donor-reactive memory T cells is an important factor in determining the relative heterologous immunity barrier posed during transplantation. Here, we hypothesized that the quality of T cell memory also potently influences the response to costimulation blockade-based immunosuppression. Using a murine skin graft model of CD8(+) memory T cell-mediated costimulation blockade resistance, we elicited donor-reactive memory T cells using three distinct types of pathogen infections. Strikingly, we observed differential efficacy of a costimulation and integrin blockade regimen based on the type of pathogen used to elicit the donor-reactive memory T cell response. Intriguingly, the most immunosuppression-sensitive memory T cell populations were composed primarily of central memory cells that possessed greater recall potential, exhibited a less differentiated phenotype, and contained more multi-cytokine producers. These data, therefore, demonstrate that the memory T cell barrier is dependent on the specific type of pathogen infection via which the donor-reactive memory T cells are elicited, and suggest that the immune stimulation history of a given transplant patient may profoundly influence the relative barrier posed by heterologous immunity during transplantation. © Copyright 2015 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  T cell biology; basic (laboratory) research/science; costimulation; fusion proteins and monoclonal antibodies: adhesion molecule specific; fusion proteins and monoclonal antibodies: costimulation molecule specific; immunobiology; immunosuppressant; immunosuppression/immune modulation; translational research/science

Mesh:

Substances:

Year:  2015        PMID: 26228897      PMCID: PMC5416935          DOI: 10.1111/ajt.13399

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  55 in total

1.  Asialo GM1(+) CD8(+) T cells play a critical role in costimulation blockade-resistant allograft rejection.

Authors:  J Trambley; A W Bingaman; A Lin; E T Elwood; S Y Waitze; J Ha; M M Durham; M Corbascio; S R Cowan; T C Pearson; C P Larsen
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

2.  Development of a novel transgenic mouse for the study of interactions between CD4 and CD8 T cells during graft rejection.

Authors:  Benjamin D Ehst; Elizabeth Ingulli; Marc K Jenkins
Journal:  Am J Transplant       Date:  2003-11       Impact factor: 8.086

3.  Control of memory CD4 T cell recall by the CD28/B7 costimulatory pathway.

Authors:  Modesta P Ndejembi; John R Teijaro; Deepa S Patke; Adam W Bingaman; Meena R Chandok; Agnes Azimzadeh; Steven G Nadler; Donna L Farber
Journal:  J Immunol       Date:  2006-12-01       Impact factor: 5.422

4.  Increased expression of the NK cell receptor KLRG1 by virus-specific CD8 T cells during persistent antigen stimulation.

Authors:  Robert Thimme; Victor Appay; Marie Koschella; Elisabeth Panther; Evelyn Roth; Andrew D Hislop; Alan B Rickinson; Sarah L Rowland-Jones; Hubert E Blum; Hanspeter Pircher
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

5.  Changes in thymic function with age and during the treatment of HIV infection.

Authors:  D C Douek; R D McFarland; P H Keiser; E A Gage; J M Massey; B F Haynes; M A Polis; A T Haase; M B Feinberg; J L Sullivan; B D Jamieson; J A Zack; L J Picker; R A Koup
Journal:  Nature       Date:  1998-12-17       Impact factor: 49.962

Review 6.  Donor-reactive T-cell stimulation history and precursor frequency: barriers to tolerance induction.

Authors:  Mandy L Ford; Allan D Kirk; Christian P Larsen
Journal:  Transplantation       Date:  2009-05-15       Impact factor: 4.939

Review 7.  Diversity in T cell memory: an embarrassment of riches.

Authors:  Stephen C Jameson; David Masopust
Journal:  Immunity       Date:  2009-12-18       Impact factor: 31.745

8.  Lack of proliferative capacity of human effector and memory T cells expressing killer cell lectinlike receptor G1 (KLRG1).

Authors:  David Voehringer; Marie Koschella; Hanspeter Pircher
Journal:  Blood       Date:  2002-07-12       Impact factor: 22.113

9.  Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections.

Authors:  Victor Appay; P Rod Dunbar; Margaret Callan; Paul Klenerman; Geraldine M A Gillespie; Laura Papagno; Graham S Ogg; Abigail King; Franziska Lechner; Celsa A Spina; Susan Little; Diane V Havlir; Douglas D Richman; Norbert Gruener; Gerd Pape; Anele Waters; Philippa Easterbrook; Mariolina Salio; Vincenzo Cerundolo; Andrew J McMichael; Sarah L Rowland-Jones
Journal:  Nat Med       Date:  2002-04       Impact factor: 53.440

10.  Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primates.

Authors:  Tim A Weaver; Ali H Charafeddine; Avinash Agarwal; Alexandra P Turner; Maria Russell; Frank V Leopardi; Robert L Kampen; Linda Stempora; Mingqing Song; Christian P Larsen; Allan D Kirk
Journal:  Nat Med       Date:  2009-07-05       Impact factor: 53.440

View more
  11 in total

Review 1.  Challenges and opportunities in targeting the CD28/CTLA-4 pathway in transplantation and autoimmunity.

Authors:  Rebecca L Crepeau; Mandy L Ford
Journal:  Expert Opin Biol Ther       Date:  2017-05-30       Impact factor: 4.388

Review 2.  Transplantation tolerance after allograft rejection.

Authors:  Michelle L Miller; Maria-Luisa Alegre; Anita S Chong
Journal:  Curr Opin Organ Transplant       Date:  2017-02       Impact factor: 2.640

Review 3.  Mechanisms of Mixed Chimerism-Based Transplant Tolerance.

Authors:  Julien Zuber; Megan Sykes
Journal:  Trends Immunol       Date:  2017-08-18       Impact factor: 16.687

4.  Selective CD28 blockade attenuates CTLA-4-dependent CD8+ memory T cell effector function and prolongs graft survival.

Authors:  Danya Liu; I Raul Badell; Mandy L Ford
Journal:  JCI Insight       Date:  2018-01-11

5.  CTLA4-Ig in combination with FTY720 promotes allograft survival in sensitized recipients.

Authors:  Stella H Khiew; Jinghui Yang; James S Young; Jianjun Chen; Qiang Wang; Dengping Yin; Vinh Vu; Michelle L Miller; Roger Sciammas; Maria-Luisa Alegre; Anita S Chong
Journal:  JCI Insight       Date:  2017-05-04

6.  CD4dim CD8bright T Cells Home to the Brain and Mediate HIV Neuroinvasion.

Authors:  Yasmeen A Albalawi; Srinivas D Narasipura; Leannie J Olivares; Lena Al-Harthi
Journal:  J Virol       Date:  2022-07-19       Impact factor: 6.549

7.  Memory T cell-mediated rejection is mitigated by FcγRIIB expression on CD8+ T cells.

Authors:  Anna B Morris; David F Pinelli; Danya Liu; Maylene Wagener; Mandy L Ford
Journal:  Am J Transplant       Date:  2020-03-24       Impact factor: 8.086

Review 8.  Role of Memory T Cells in Allograft Rejection and Tolerance.

Authors:  Gilles Benichou; Bruno Gonzalez; Jose Marino; Katayoun Ayasoufi; Anna Valujskikh
Journal:  Front Immunol       Date:  2017-02-28       Impact factor: 7.561

9.  Optogenetic Peripheral Nerve Immunogenicity.

Authors:  Benjamin E Maimon; Maurizio Diaz; Emilie C M Revol; Alexis M Schneider; Ben Leaker; Claudia E Varela; Shriya Srinivasan; Matthew B Weber; Hugh M Herr
Journal:  Sci Rep       Date:  2018-09-19       Impact factor: 4.379

10.  T Cell Repertoire Maturation Induced by Persistent and Latent Viral Infection Is Insufficient to Induce Costimulation Blockade Resistant Organ Allograft Rejection in Mice.

Authors:  Jaclyn R Espinosa; Danny Mou; Bartley W Adams; Louis R DiBernardo; Andrea L MacDonald; MacKenzie McRae; Allison N Miller; Mingqing Song; Linda L Stempora; Jun Wang; Neal N Iwakoshi; Allan D Kirk
Journal:  Front Immunol       Date:  2018-06-15       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.